A major new review from Yale (Moen, Baker, Iwasaki, 2025) offers the most comprehensive picture yet of what SARS-CoV-2 does to the nervous system.
The conclusion is stark:
Long COVID is a chronic neuroimmune disorder affecting brain, spinal cord, and peripheral nerves.🧵
Warning Sign #1: The pandemic didn’t end - it just changed shape.
The virus keeps evolving. The acute symptoms may fade.
But for many, the infection never truly ends.
Even young, previously healthy people experience:
mental fog,
dizziness when standing,
sensory disturbances,
exhaustion after minimal effort,
racing heart.
That’s Long COVID.
Warning Sign #2: The virus leaves behind molecular debris - and the immune system won’t let it go.
Sometimes it’s spike protein fragments in the blood.
Sometimes viral RNA in the olfactory bulb or even the skull.
This triggers persistent immune alarms:
T cells get activated
Inflammation spreads to the brain
Neuronal connections start breaking down
The war continues - long after the virus is gone.
Warning Sign #3: The brain gets sick - even when standard scans look “normal.”
MRI often misses it. But PET imaging shows:
reduced glucose metabolism in the brainstem,
limbic inflammation,
microglia digesting synapses.
Patients say:
“I know what I want to say, but I can’t get it out.”
It’s inflammatory disruption of higher brain function.
Warning Sign #4: It’s not just the brain - the body’s autopilot system begins to fail.
The autonomic nervous system - which controls heart rate, blood pressure, digestion - goes haywire.
Blood pools in the legs; the brain is starved of oxygen.
POTS, dizziness, blackouts, heat intolerance
Even the vagus nerve - the main communication line between brain and body - shows structural damage in some studies.
Warning Sign #5: The immune system may start attacking the nervous system itself.
After infection, some people develop autoantibodies:
against adrenergic receptors,
against cholinergic synapses,
against neurons.
In experiments, these antibodies from Long COVID patients were transferred to mice - and caused neurological symptoms.
This isn’t just immune activation. It’s autoimmunity.
Warning Sign #6: Smell loss isn’t just a quirky symptom - it’s a red flag.
Olfactory tissue often shows:
inflammation,
neuronal destruction,
lingering T cells months after infection.
Even after viral clearance, the damage and local immune activity can persist - blocking recovery.
Smell loss may signal long-term damage to the central nervous system.
Warning Sign #7: Spike protein isn't just debris - it can fuel clotting and inflammation.
Persistent spike fragments have been found in blood and even skull tissue months post-infection.
They bind fibrin - form resistant microclots
These can obstruct capillaries, disrupt brain perfusion, and trigger microglial activation, cause ischemia-reperfusion injury
Even without active virus, brain tissue can be damaged by the aftermath of infection.
Warning Sign #8: SARS-CoV-2 may accelerate brain aging.
Evidence from autopsies, mice, and imaging shows:
damage to dopamine neurons,
loss of neurogenesis in the hippocampus,
inflammatory profiles resembling Parkinson’s and Alzheimer’s.
For some, COVID acts as an accelerant for neurodegenerative processes.
Warning Sign #9: No one is exempt. Not the young. Not the recovered.
Reinfections raise the risk.
Immunological imprinting may alter long-term responses.
Long COVID is not rare - it’s the aftermath of a system-wide disruption.
With no diagnostic test.
No cure.
And millions affected globally.
Bottom line: Long COVID isn’t “just fatigue.”
It’s:
chronic neuroinflammation,
immune dysregulation,
vascular dysfunction,
autonomic breakdown.
It’s a warning that infectious disease can leave lasting biological scars - not just in “high-risk” groups, but in anyone. @szupraha @ZdravkoOnline
During the pandemic, physician @leanhealth reported something important.
COVID patients who slept next to bedside air filters often seemed to have milder disease - possibly because they were not re-inhaling virus-laden air for eight hours every night🧵
A new hypothesis paper now points in the same direction using CT data. Cleaner air may not only reduce transmission. It may also reduce how deeply SARS-CoV-2 affects the lungs.
The idea is simple. The virus first replicates in the upper airways. An infected person then exhales tiny virus-containing aerosols. In poorly ventilated indoor spaces, these particles can build up and be inhaled deep into the lungs.
A population-based study raises a concerning possibility - after COVID-19, the risk curves for newly detected diabetes may continue to drift apart over time🧵
The cohort included 248,176 adults without prior diabetes
124,150 SARS-CoV-2 positive and 124,026 test-negative controls.
The result was modest but statistically significant.
New diabetes was detected in
0.60% of the positive group
0.53% of the negative group
Hazard ratio 1.13, 95% CI 1.02-1.25
We are still trying to place Long COVID into a biologically coherent framework.
This study is interesting because immune activation, antiviral signaling, metabolism, mitochondria, cell survival do not appear as separate findings - but as parts of one connected system🧵
A possible axis is this
something keeps innate immunity on alert - immune cells produce inflammatory signals - their metabolism shifts - mitochondria come under stress - stressed mitochondria can further amplify immune activation.
That is a loop, not a list.
The study compared 50 people with Long COVID with 50 recovered controls around 10 months after SARS-CoV-2.
Both groups had been infected. The key difference was whether symptoms persisted.
Even in the Omicron era, SARS-CoV-2 was linked to a several-fold increase in serious thromboembolic and cardiovascular events - and that risk persisted for months after infection🧵
A new European preprint cohort study looked at ~780,000 people with COVID-19 and 7.6 million pre-pandemic controls across three health databases in the UK, the Netherlands and Spain.
The main finding is hard to ignore.
In the first 30 days after infection, the standardized incidence of venous thromboembolism was about 3.6-4.1 times higher than expected!
A new narrative review by Kell, Zhao & Pretorius looks at Long COVID through the lens of microcirculation. The idea that persistent fibrinaloid microclots may contribute to impaired blood flow in the smallest vessels.🧵
This is not a systematic review or meta-analysis. It is better read as a broad mechanistic argument. A way to connect existing findings on inflammation, endothelial dysfunction, coagulation, fibrinolysis and Long COVID symptoms.
The central idea is that, in some inflammatory states, blood may form abnormal microclots containing fibrin and other proteins in an amyloid-like form. Fibrinaloid microclots.
A new warning study that deserves attention.
SARS-CoV-2 leaves a long-term endothelial and metabolic footprint in the blood months after infection - even in people without obvious Long COVID symptoms.
And that matters🧵
Researchers followed 262 adults in Germany and measured blood biomarkers about 37 weeks after infection - roughly 9 months later.
People who had previously had COVID showed higher markers of endothelial dysfunction and tissue stress, including soluble thrombomodulin and LDH, compared with never-infected controls.